A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager." This type of immunotherapy ignites our own ...
(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...
Carotenoids like beta-carotene, lycopene, lutein, and zeaxanthin may improve skin, heart, and bone health or prevent prostate ...
The six times Olympic cycling champion says a "bucket list" is less important than learning to appreciate special small things "in the moment".
NEW YORK, NY, UNITED STATES, March 18, 2026 /EINPresswire.com/ -- Liv Hospital today launched an informative guide to ...
This may not apply in your husband’s case, but it’s worth having the conversation. The two meds Goldstein prescribes for men are flibanserin (Addyi), an oral tablet taken d ...
UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...
UPMC Hillman Cancer Center is exploring everything radiation treatment can treat, and the success has been life-changing for people.
Someday soon, doctors who don’t run their patients’ records through an AI model will be considered negligent. At least, that’s what Steve Brown thinks. He’s the founder of CureWise, an app designed to ...
Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results